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Ghazala Sadiq,a Neil Feeder a  
a The Cambridge Crystallographic Data Centre, Cambridge, UK, sadiq@ccdc.cam.ac.uk 
 
ABSTRACT: Solid form selection of an active pharmaceutical ingredient (API) is a key stage in the drug 
product development process. Uncontrolled crystal form polymorphism can have a critical impact on 
1 2 
of hydrogen bonds in the more stable form. The application of informatics-based assessment3 of new 
solid forms complements experimental studies and provides a deeper understanding of the qualities 
of the structure. The information provided by structural analyses is incorporated into the assessment of 
risk for the drug candidate. 
 
Structural informatics techniques, which harness the knowledge contained within over 850,000 entries 
in the Cambridge Structural Database (CSD)3, are quick to apply and are straightforward to use, 
allowing continuous assessment of progressing drug candidates. Software including such 
methodologies is being developed under the guidance of the Crystal Form Consortium (CFC), a 
partnership between the CCDC and several global pharmaceutical and agrochemical companies.  
The basis of a structural informa 4 is to analyse the 
structure of a specific crystal form in comparison to other similar structures in the CSD and to relate this 
commonality to thermodynamic stability. Deviation from the norm for the crystal form under 
investigation can then be taken as an indication that a more stable polymorph might exist for that 
molecule. The structural features studied typically focus on crystal packing, intramolecular interactions, 
intermolecular interactions, propensity of hydrogen bonds and the geometry of interactions observed.  
 
CSD-
Materials are used to carry out a health check, and how the potential application of these tools can be 
used to minimise risk in solid form design. 
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[2] S. Cajigal, Neurology Today, 2008, 8, 1 & 8 
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Matched molecular structures in the Cambridge Structural Database: potential use for crystal 
engineering 
I. Giangrecoa, J. C. Colea and Neil Feedera 
a The Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge, CB2 1EZ, UK, 
giangreco@ccdc.cam.ac.uk 
 
ABSTRACT: With over 850,000 small-molecule crystal structures, the Cambridge Structural Database 
(CSD) features a wealth of information for understanding molecular packing and crystal engineering. 
Within this vast dataset are numerous pairs of molecules related by a single well-defined structural 
transformation. In drug discovery, analysis of such pairs is used to understand how structural 
modifications will affect the properties or binding affinity of a molecule. This type of investigation is not 
common for crystal structures, but has the potential to provide critical insights into how simple 
chemical transformations affect the structure and properties of solid forms.  
Here, we outline the process of finding all matched molecular pairs in the CSD. We will then highlight 
the potential of this repository to inform on crystal engineering in a variety of ways. One example is to 
explore how transformations around acyclic single bonds (e.g. a terminal methyl group becoming a Cl 
atom) affect the packing of a molecule. There are over 12,000 such transformations represented in the 
CSD, which allows us to determine which functional group changes are more or less likely to disrupt or 
change the packing of a molecule in the solid state. 
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The Effect of Gel on the Phases Stability: The Case of Cd-bpp MOF system 
Fabio Beghia, Silvia Rizzatoa, Massimo Moretb 
a Department of Chemistry, University of Milan, Via Golgi 19, Milan, Italy 
b Materials Science Department, University of Milan (Bicocca), Via Roberto Cozzi 55, Milan, Italy 
 
ABSTRACT: It is well known how the crystallization in gel media represents a very useful technique to 
growth crystals of high quality but also an alternative way to generate new crystalline phases.[1] In 
crystallization process toward specific polymorphs or unusual phases that cannot precipitate from 
solution.[2] 
 
In the present work we report a similar behaviour observed for the system CdCl2 (M) - 1, 3-bis(4-
pyridyl)propane (L), that leads to the formation of different crystalline phases, that is:  
 
A     B     C 
(A)3D coordination polymer, sra topology 3D [Cd2(bpp)3Cl2]·H2O (3D-sra). [4] 
(B)3D coordination polymer, diamantoid topology [Cd(bpp)2Cl2]·H2O (3D-dia). [3] 
(C)1D coordination polymer [Cd(bpp)3Cl2]·2H2O (1D-Cd). [3] 
 
An exhaustive screening has been performed by varying a number of crystallization parameters: total 
concentration and molar ratio of the reactants, gel strength, experimental set up for counterdiffusion 
technique. We always carried out the comparison with the behaviour of the same system in solution. 
We observe significant gel effects of phase stability. In particular increasing gel concentration is 
related with a global movement of the phase diagram towards lesser values of molar ratio.  
 
The gel also has strongly influenced the morphology of the crystalline material, in particular 3D-dia 
crystals has revealed different kind of modification. They have displayed surface roughening and 
crystal elongations until disappearance of a recognizable morphology. This phase also form peculiar 
aggregates that suggest non-classical crystallization path, as oriented attachment mechanism. 
 
 
 
 
 
 
 
 
 
 
 
 
 
References: 
[1] Mahieux,J.; Sanselme,M.; Coquerel,G. Cryst. Growth Des. 2013, 13, 908-917. 
[2] Diao,Y.; Whaley, K.E. and Trout, B.L.  J. Am. Chem. Soc. 2012, 134, 673-684. 
[3] L. Carlucci, G. Ciani, M. Moret, D. M. Proserpio, and S. Rizzato Chem. Mater., 2002, 14, 12 16. 
[4] F. Luo, Y. xia Che, and J. min Zheng, Inorg. Chem. Commun. 2006, 9, 856-858. 
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Engineering of solid-state supramolecular rotors through halogen bonding 
Luca Catalano,a,b Salvador Pérez-Estrada,b Giancarlo Terraneo,a Pierangelo Metrangoloa,c and Miguel 
A. Garcia-Garibayb 
a  
bDepartment of Chemistry and Biochemistry, University of California Los Angeles, Los Angeles, USA 
cHYBER Center of Excellence, Department of Applied Physics, Aalto University, Espoo, Finland 
luca.catalano@polimi.it 
 
ABSTRACT: Amphydynamic crystals are materials built to possess rapidly moving components in the 
solid state. Nowadays there is a growing interest in this class of compounds for the development of 
new functional materials and molecular machines. [1] The aim of our research is to take advantage of 
crystal engineering principles to assemble stators and rotators into cocrystals showing highly efficient 
molecular dynamics. This strategy has few advantages such as its intrinsic flexibility and hence the 
trivial access to a vast number of different supramolecular rotors. Firstly, we were able to synthesize 
crystalline supramolecular rotors selfassembled by halogen bonding (XB) of diazabicylo[2.2.2]octane 
(DABCO), a well known D3h-symmetric cylindrically shaped rotator, and a set of five fluorine-
substituted iodobenzenes, acting as strong halogen bond donors, that take the role of the stators. The 
obtained amphidynamic cocrystals show excellent dynamics performance and XB works both as self-
assembly driving force and main axle of rotation. [2] Based on these results, we designed and 
synthesized a series of isomorphous amphidynamic cocrystals based on XB. By carefully studying their 
inner dynamics and thanks to their structural similarities, we were able to distinguish the enhalpic and 
entropic components of the rotational free energy barrier. What is more, one of the cocrystal show the 
lowest ever-reported activation energy of the rotational process. [3] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
References: 
[1] C.S. Vogelsberg, M.A. Garcia-Garibay, Chem. Soc. Rev. 2012, 41, 1892-1910. 
[2] L. Catalano, S. Pérez-Estrada, G. Terraneo, T. Pilati, G. Resnati, P. Metrangolo, M.A. Garcia-Garibay, J. Am. Chem. 
Soc. 2015, 137, 15386-15389. 
[3] L. Catalano, S. Pérez-Estrada, H.-H. Wang, A. J.-L. Ayitou, S. I. Khan, G. Terraneo, P. Metrangolo, S. Brown, M.A. 
Garcia-Garibay J. Am. Chem. Soc. 2017, 139, 843-848. 
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Prediction and verification of co-crystal formation 
Argyro Chatziadia,b Eliska Skorepova,a Miroslav Soos,a Ludek Ridvanb 
a Chemical Engineering Department, UCT, Prague, Czech Republic, chatziaa@vscht.cz 
b Zentiva Company, Prague, Czech Republic, Ludek.Ridvan@zentiva.cz 
 
ABSTRACT: The experimental screening of co-crystal forms of active pharmaceutical ingredients (APIs) 
is challenging, as well as time and money consuming. For this purpose, there have been proposed 
several computational methods as possible ways to predict which substances (coformers) would be 
more likely to form a co-crystal with a given API. [1, 2] Each method depends on different factors that can 
influence the success of this formation. 
 
In this work, we applied two of these methods to evaluate their ability to predict the co-crystallization 
of two pharmaceutical compounds, Lacosamide and Ivabradine hydrochloride, each with 10 different 
coformers. These methods are based on the shape similarity of the molecules of API and coformer and 
on their ability to form hydrogen bonds.[3, 4] More specifically, the first one is a method to predict if 2 
molecules will form a co-crystal based on the comparison of each of their molecular descriptors 
(polarity, dipole moment, 3 simple shape descriptors). The second method is a knowledge-based 
methodology to assess and predict hydrogen bond formation comparing all their possible homo- and 
hetero- interactions. 
 
The results of the two methods were quite successful to predict the formation of the experimentally 
observed cocrystals of Ivabradine hydrochloride with (R)-mandelic acid and (S)-mandelic acid and of 
the cocrystal of Lacosamide with urea. It is worth noticing that there was a good agreement between 
the computational predictions provided by the two methods.  
 
As a conclusion, we can say that these two computational methods can facilitate the assessment of the 
likelihood for a cocrystal to form. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
References: 
[1] Mohamed, S., Tocher, D. A. & Price, S. L., International Journal of Pharmaceutics, 2011, 418, 187 198.  
[2] Loschen, C. & Klamt, A., J. Pharm. Pharmacol., 2015, 67, 803 811.  
[3] Fabian, L., Cambridge structural database analysis of molecular complementarity in cocrystals, Cryst Growth. Des, 
2009, 9, 1446-1463.  
[4] Wood, P. et al., Knowledge-based approaches to co-crystal design, CrystEngComm, 2014, 16, 5839-5848. 
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Suppressing Hydrate Formation in Metoclopramide HCl by Cocrystallization 
Yuda Prasetya Nugraha,a  Hidehiro Uekusab 
aDepartment of Chemistry and Materials Science, Tokyo Institute of Technology, Japan, 
nugraha.y.ac@m.titech.ac.jp 
bDepartment of Chemistry, Tokyo Institute of Technology, Japan 
 
ABSTRACT: From a pharmaceutical point of view, controlling the crystalline form of API in the drug 
product is crucial in terms of pharmaceutical quality system. Hydrate crystal form is often preferred 
among commercial drug products due to its stability against high humidity.[1] However, the hydrate 
ed pre- -anhydrate transformation 
by different temperature or humidity conditions can occur during manufacturing process or under 
storage in ambient condition.[2] In our previous study, the commercially marketed metoclopramide HCl 
monohydrate form transformed into anhydrate form at 75°C, then it hydrated by exposure to humidity 
of RH > 60%.  Also, their crystal structure features explained the transformation mechanisms.  
 
In this research, we explored more stable crystalline form of metoclopramide HCl by utilizing 
multicomponent crystal formation with oxalic acid as a coformer. Crystal structure analysis revealed 
that in this salt cocrystal, all hydrogen bond donors and acceptors were utilized comparable to those 
observed in the monohydrate form. Importantly, because of this feature, the cocrystal has a good 
stability under exposure to high humidity environment and also in slurry experiment in water. Besides, 
this cocrystal form is stable up to 150°C temperature.  This research emphasizes the role of 
cocrystallization on improving the multiple stabilities of highly soluble drug. 
 
 
 
 
 
 
References: 
[1] M. D. Eddleston, N. Madusanka, W. Jones, J. Pharm. Sci. 2014, 103, 2865 2870. 
[2] M. Ito, K. Nambu, A. Sakon, H. Uekusa, E. Yonemochi, S. Noguchi, K. Terada, J. Pharm. Sci. 2017, 106, 859 865. 
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Thorough Study of the Ibrutinib Polymorphs: Emphasizing the Importance of Desolvation 
a,b,c a b c a b 
aDept. of Chemical Engineering, University of Chemistry and Technology Prague, Prague, 
vit.zvonicek@vscht.cz 
bZentiva k.s., Prague 
cInstitute of Physics of the Czech Academy of Sciences, Prague 
 
ABSTRACT: 
active pharmaceutical ingredients (APIs) are highly prone to polymorphism. Different solid forms may 
have significantly altered properties such as solubility, physical and chemical stability or 
reproducibility.[1,2] 
the final drug product,[3] or they can make the production of the desired solid form challenging or 
even impossible.[4]  Therefore, thorough study of the polymorphism is a crucial step for the API and the 
whole pharmaceutical development. In our research, we focused on the detailed description of the 
polymorphs of Ibrutinib, a recently approved tyrosine kinase inhibitor used for treatment of non-
Hodgkin lymphomas. Ibrutinib has three polymorphs described in the patent literature: form A, form B 
and form C.[5] In our study, we have prepared single crystals of two of its polymorphs (the most stable 
form A and metastable form C) and solved their crystal structures using X-ray diffraction. The third 
polymorph (form B) was obtained only as a powder sample. In addition, we have also prepared a 
single crystal and solved a crystal structure of Ibrutinib methanol solvate (form F). This solvate was 
found to be highly unstable channel solvate, desolvating to one of the Ibrutinib polymorphs, form C. 
The mentioned desolvation process was found to be the only, so far known, method of the preparation 
of the form C. Further, the single-crystal of the solvate was used to prepare the single crystal of the 
form C by a single-crystal to single-crystal transformation. Analysis of their crystal structures revealed 
high similarity between the solvate and the desolvation polymorph, where the major difference is a 
closure of the vacant channel left after the methanol escape from the structure. Also, the kinetics of the 
desolvation process of the methanol solvate was measured using a time dependent XRPD. Forms A, B 
and C were further characterized by a standard solid state methods such as DSC, TGA, DVS and XRPD. 
To reveal their applicability in the drug production, dissolution profiles were measured for those three 
forms, with the form B and C having almost 3 times higher dissolution rate in comparison with the form 
A. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
References: 
[1] L. Jia, Q. Zhang, J. R. Wang, X. Mei, CrystEngComm 2015, 17 (39), 7500 7509. 
[2] G. R. Desiraju, J. J.Vittal, A. Ramanan, Crystal Engineering: A Textbook; World Scientific, 2011. 
[3] Y. Chi, C. Liu, T. Ren, X. Wang, Q. Yang, Z. Yang, Y. Yang, S. Yang, J. Gu, C. Hu, Cryst. Growth Des. 2016, 16 (6), 
3180 3189. 
[4] J. Bernstein, R. J. Davey, J. O. Henck, Angew. Chem. Int. Ed. 1999, 38 (23), 3440 3461. 
[5] M. Smyth, E. Goldman, D. Wirth, N. Purro, e Kinase Inhibitor, December 13, 
2013, WO/2013/184572. 
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Polymorphs and surface induced structures in drug thin films investigated by Raman spectroscopy. 
A. Rivalta,a T. Salzillo,a O. Werzer,b E. Venuti,a R.G. Della Vallea and A. Brillantea 
a -Udr Bologna, University of Bologna, 
Viale del Risorgimento 4, 40136 Bologna (Italy) - arianna.rivalta2@unibo.it 
b Institute of Pharmaceutical Sciences, Department of Pharmaceutical Technology, University of Graz, 
Universitätsplatz 1, 8010 Graz, Austria 
 
ABSTRACT: The study of polymorphism plays an important role in several fields of materials science, 
with relevant applications in technology and pharmaceutics. This contribution aims to show how the 
polymorph phenomenon can be studied by means of confocal Raman microscopy in the lattice 
phonons region (Figure 1). Using this  approach allows for an effective in situ phase recognition, [1] with 
the possibility of obtaining a topography of the chemical purity and polymorphism of the sample by 
mapping the Raman signal at a micrometric resolution. [2]     Recently, there is a growing interest in a 
new generation of crystalline forms obtained in thin films, which are defined as surface-induced 
polymorphs (SIPs). In pharmaceutical science it has been demonstrated that SIPs might indeed exhibit 
different performances like enhanced dissolution rates for drug release. A full characterization of the 
SIPs is still challenging and a number of experimental and computational tools are necessary to 
unambiguously identify their nature and characteristics. [3] 
 
In the model case of phenytoin (5,5-
diphenylimidazolidine-2,4-dione) Raman spectroscopy 
has turned out to be a valuable support to the structural 
characterization of a SIP. [3] By a careful evaluation of 
different Raman bands, together with the morphological 
differences observed in the microscope, regions of 
distinct polymorphs could be identified. This very 
information was recently inaccessible, as morphologies 
could not directly be connected to any morphology. 
 
As a further example of the application of the Raman 
technique, we also report on the investigation of the 
relative stability of the paracetamol (N-(4-
hydroxyphenyl)ethanamide) phases in spin coated films 
on different substrates over a wide temperature range. 
In particular, the metastable form III has been found to 
show the longest lifetime on record when obtained in 
the film form on suitable substrates. 
 
 
Figure 1: Lattice phonon of phenytoin (and molecular structure) in the bulk and different forms found on substrate. 
Markers show the peaks of the substrate. 
 
 
 
 
References: 
[1] A. Brillante, I. Bilotti, R. G. Della Valle, E. Venuti, M. Mas-Torrent, C. Rovira, Y. Yamashita. Chem. Phys. Lett., 2012, 
523, 74-77. 
[2] A. Brillante, I. Bilotti, R. G. Della Valle, E. Venuti and A. Girlando. Cryst. Eng. Comm., 2008, 10, 937-946. 
[3] Daniela Reischl, Christian Röthel, Paul Christian, Eva Roblegg, Heike M. A. Ehmann, Ingo Salzmann and Oliver 
Werzer. Cryst. Growth Des. 2015, 15, 4687-4693. 
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Controlling needle growth from both stacking and hydrogen-bonding. 
Francesco Civati,a  Patrick McArdle,a Andrea Erxleben a 
a School of Chemistry, National University of Ireland Galway, f.civati1@nuigalway.ie 
 
ABSTRACT: A given substance can crystallize in diverse habits. Needle like crystals are an undesired 
shape in the pharma industry because they have poor flow proprieties, poor filterability and poor 
compressibility.[1] Two main effects can drive the formation of needle like crystals, one van der Waals 
contact stacking interactions and H bonding motifs.[2] In this work two molecules with needle like 
-hydroxy- -bi(cyclohexane)]-1-carbonitrile with hydrogen 
the crystal habit using different approaches.  
 
-hydroxy- -bi(cyclohexane)]-1-carbonitrile it was shown that the use of solvents of 
different polarity drastically modify the H-bond motif and the habit of the crystals. The use of a highly 
polar solvent leads to the formation of block like crystals while less polar solvents cause needle like 
growth. 
 
In the case of Diflunisal a different approach was selected. A library of tailor made molecules (esters 
and amides) was synthesized and used as additives in the crystallization process. None of the 
molecules selected affected the final habit. For this reason a new low attrition method was 
investigated. A vial with a supersaturated solution was fixed to an engine that move the vial, the 
spinning frequency is controlled by a variable voltage transformer, using voltages in the range of 10 to 
12 volts. During this movement caused by the engine the crystals are slowly changing the dimensions 
due to a mass action effect. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
References: 
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9th -6 June 2017        12 
 
POSTER No. 10 
 
Prediction and Experimental Validation of Solid Solutions and Isopolymorphs of Cytosine/5-
Flucytosine 
Doris E. Braun,a Volker Kahlenberg,b Ulrich J. Griessera 
aInstitute of Pharmacy, University of Innsbruck, Austria, doris.braun@uibk.ac.at 
bInstitute of Mineralogy and Petrography, University of Innsbruck, Austria 
 
ABSTRACT: The structural, temperature- and moisture dependent stability features of cytosine [1,2] and 
5-flucytosine [3] solid forms, two pharmaceutically important compounds, were rationalised using 
complementary experimental and computational approaches. Moisture sorption/desorption, water 
activity, thermal analysis and calorimetry were applied to determine the stability ranges of hydrate ↔ 
anhydrate systems, while X-ray diffraction, IR spectroscopy and crystal structure prediction provided 
the molecular level understanding. 
 
The computed crystal energy landscapes for the anhydrous forms, monohydrates and 1:1 cocrystals 
not only revealed that the substitution of C5 (H or F) controls the packing and properties of the solid 
forms, but also have enabled the finding of novel solid solutions of the two substances, with interesting 
practical features. All neat, hydrated and solvated solid solutions are isostructural with the 5-
flucysosine solid forms and exist only if more than 20% of 5-flucytosine is present. In the case of the 
monohydrate solid solution, the new phase shows better thermal- and moisture-dependent stability 
properties than its pure structure, 5-flucytosine monohydrate I.  
 
The chemical exchange of the C5 cytosine proton with a F-atom not only influences the predominance 
of hydrogen-bonding motifs in monohydrate structures but more important the way in which 
hydrogen-bonded ribbons are linked through water into three-dimensional packings. In contrast, the 
hydrogen ↔ fluorine atom exchange in the anhydrous compounds does not affect the predominance 
of the experimentally observed ribbon motif, but its 3D packing preferentiality. 
 
To conclude, this study is another successful demonstration of the complementarity of computational 
and experimental screening and characterisation methods. The computed crystal energy landscapes 
are an important tool not only for interpreting the range of experimental solid forms but also for 
proposing and targeting crystallisation experiments using isomorphs seeds/templates to produce 
novel solid forms. Furthermore, the computed structures can support structure solution from 
laboratory powder X-ray diffraction data. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
References: 
[1] R. J. McClure, B. M. Craven, Acta Crystallogr., Sect. B. 1973, 29, 1234-1238. 
[2] B. Sridhar, J. B. Nanubolu, K. Ravikumar, Acta Crystallogr., Sect. C. 2015, 71, 128-135. 
[3] A. T. Hulme, D. A. Tocher, Cryst. Growth Des. 2006, 6, 481-487. 
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Multicomponent crystals of Leucine-Leucine dipeptides 
Paolo Lucaioli,a Elisa Nauha,b Ishwar Singh,a Nicholas Blagdena 
aCollege of Science, School of Pharmacy, University of Lincoln, plucaioli@lincoln.ac.uk 
bCollege of Science, School of Chemistry, University of Lincoln 
 
ABSTRACT: Biologicals are having a more important role as therapeutic agents. They can be 
composed of proteins, sugar, or nucleic acid and sometimes they might represent the only efficient 
way to treat a specific disease. The solid-state 
form due to the fact that these compounds exist in the amorphous state with consequent 
disadvantageous therapeutic and pre-formulation properties (e.g. questionable stability, 
unpredictable solubility and bioavailability). 
 
A possible contemporary solution to this crystallisation ability issue, is the preparation of crystal forms 
of these biological molecules using and applying the concepts of crystal engineering and molecular 
complexes.  
 
Leucine-leucine dipeptide has been synthesized through Fmoc Solid Phase Peptide Synthesis and it 
was co-crystallised along with a list of different co-formers. The Leu-Leu dipeptide is a good starting 
material due to different structural properties (e.g. small size, good amount of hydrogen bond donors 
and acceptors, no additional chemical functionalities on the hydrophobic side chains, only solvates are 
reported in the Cambridge Structural Database). 
 
Single crystal X-ray diffraction analysis show the formation of different novel crystal structures 
containing both the dipeptide and co-formers with similar multi-layered crystal packings. An 
interesting nanotube structure has been obtained while trying to co-crystallise the dipeptide and 4-
dimethylamino pyridine. 
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A thermal gradient approach towards polymorph selection in thin films 
Basab Chattopadhyay,a Yves H. Geerts b 
a Laboratoire de Chimie des Polymères, Faculté des Sciences, Université Libre de Bruxelles CP206/01, 
Campus de la Plaine, 1050 Brussels, Belgium, basab.chattopadhyay@ulb.ac.be 
 
ABSTRACT: Polymorphism can be defined as the intrinsic ability of a solid material to exist in two or 
more crystal forms which may differ in the molecular conformation and/or crystal packing. It is linked to 
the unpred
10 KJ/mol. The phenomenon is generally understood in terms of nucleation, i.e. once a nucleus of a 
given phase has appeared, growth continue in the same phase without any subsequent phase 
transition. Due to its dramatic influence on material properties, polymorphism is of great importance 
for industrial sectors like pharmaceuticals, fertilizers, explosives, pigments, and organic electronics. 
Although an extensive body of research is available in this topic, some elements key to the 
understanding of polymorphism is still missing. To this extent we sought to understand the role of heat 
flux in polymorphic control and phase transitions with a model system, acetaminophen. This is 
experimentally facilitated by a temperature gradient heating stage which essentially consists of two 
independent heating elements separated by a distance of 2.5 mm. [1]  
 
One of the heating elements is set at a temperature, above the melting temperature (hot side) while 
the other at a temperature below the crystallization temperature (cold side) of acetaminophen. 
Structural evolution is then followed as thin films of acetaminophen are translated from the hot zone to 
the cold zone. Thin films are ideal model systems, because of the absence of convection, heat 
transport occurs only by diffusion. In this presentation, we report on the crystallization of polymorphs 
of acetaminophen as a function of thermal gradient parameters (magnitude of the gradient, sample 
to control direction and the rate of crystal growth. This allows to decouple nucleation and growth.[2] A 
detailed structural analysis combining polarized optical microscopy (POM) and X-ray diffraction (out-
of-plane, in-plane) has been carried out to characterize different crystalline forms produced by the 
thermal gradient technique. The resulting polymorphic forms have been found to have high phase 
purity and exhibit remarkable stability over time. 
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ABSTRACT: Pharmaceutical Cocrystals [1] (CCs) are crystalline solids, which consist of an active 
pharmaceutical ingredient (API) and at least one cocrystal former (CCF). CCs can potentially improve 
physicochemical properties, such as solubility, dissolution rate, melting point and even bioavailability 
compared with their parent APIs. Ternary phase diagram[2]can describe the stability and 
thermodynamic characteristics of a cocrystal system. That is very important to design the crystallization 
operation and develop an up-scaled process. 
 
In my project, piracetam and a 1:1 stoichiometric amount of CaCl2 were grinded for 90min at 30Hz by 
solvent-drop grinding method, leading to form the piracetam2: CaCl2: H2O co-crystal[3]. To make the 
ternary phase diagram, we added piracetam and CaCl2 into water with piracetam/CaCl2 ratio from 0 to 
1. The suspensions were stirred in sealed vials at 298.15K for 48h to make sure the system reached 
thermodynamic equilibrium. After that, the sample solids were obtained by vacuum filtration and were 
characterized by XRPD measurement. Then we determined the solubility of the different compositions 
to create the liquid surface in this ternary phase diagram. 
 
 
 
Figure 1. Piracetam-CaCl2 ternary phase diagram in water at 25℃ (mole fraction) 
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Greener solid state synthesis: Halogen-Bonded Directed Stereoselective Photodimerization of 
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ABSTRACT: Supramolecular chemistry has been utilized to orient C=C bonds in an appropriate 
orientation for stereo-selective photodimerization in a non-solvent way. We report herein the 
stereoselective photodimerization of Vitamin K3 using fascinating templates with ditopic halogen 
bond donors.[1] As a consequence of cocrystal formation with these templates, reactive C=C bonds of 
neighbouring Vitamin K3 molecules stay at a center-to-center distance below 4.2 Å and conform to the 
criteria of Schmidt for photodimerization reaction. Under UV irradiation, Vitamin K3 molecules 
undergo a [2+2] photodimerization in the solid in a stereoselective and quantitative manner. This is by 
far the first case wherein both the preparation of the cocrystals and the purification process were 
r 
photodimerization, in the one hand, photodimer can be separated from the crude photoproduct by 
simply sublimating the templates. On the other hand, the templates are environmentally sustainable 
that can be recovered and recycled by condensation. Thus, both the preparation and separation of the 
photodimers are conducted in the absence of solvent. 
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ABSTRACT: 65 million years ago an asteroid hit the Earth and initiated the extinction of dinosaurs. 
Vitamin D deficiency was thought to be one of main factors, as the global darkness led to the inability 
to produce the vitamin D which would have been essential for the maintenance of the massive 
skeletons of the dinosaurs. Vitamin D3 (VD3), a steroid hormone, has mainly been known for its effects 
on bone and osteoporosis. The current therapeutic practices expand into such markets as cancer 
research, pediatrics, nephrology, dermatology, immunology, and genetics. Although VD3 has been 
used in medicine, food and feed industry for several decades, the solid-state of this interesting vitamin 
is not comprehensively studied. We herein report the discovery of four cocrystals constructed with a 
set of collective hydrogen-bond interactions.  
 
These cocrystals were formed through an unexpected conformationally selective crystallization 
process and were found to present superior physicochemical properties compared with vitamin D3 
itself. It was found that two polymorphic forms of VD2-VD3 cocrystal exhibited dramatically different 
physicochemical stabilities due to the packing style and distance of C7-C19. The distance between C7 
and C19 is a key factor to indicate the vulnerability of vitamin D to photo- and thermos- induced 
topochemical cyclization reactions. 
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ABSTRACT: In recent years, many strategies such as chemosynthesis and solid-state studies have been 
taken in attempt to discover reversible mechanochromism luminescent (MCL) materials and alter their 
fluorescent colors. Here, we report three polymorphs, two hydrates and six solvates of Emodin (EM)  a 
naturally occurring fluorescent dye. Obvious differences in their fluorescent properties were 
presented. Notably, form I and amorphous of EM exhibited reversible fluorescent color changes in 
response to both thermo stress and mechanical stimulation.[1]  
 
Moreover, S2 (ethanol) and S4 (acetonitrile) presented the most significant differences among EM 
solvates and they showed vapor triggered reversible fluorescent color changes. The reversible 
processes of both form I to amorphous and S2 to S4 were well exhibited in the writing-erasing process 
on the cast filter paper made by EM. It was found that different kinds of H- -
existed in solid states of EM, which illustrated the reasons why they exhibited different fluorescent 
colors. This work provides a new approach to find eco-friendly and metal-free organic MCL materials 
that sensitive to vapor, mechanical and thermal stress without chemical synthesis and a demonstration 
of potential application for EM in organic vapor sensing and security ink material through controlling 
solid-state transition processes. 
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ABSTRACT: Fabrication of a thin film of organic electronics materials is very important for the 
preparation of effective optoelectronic devices [1]. Therefore, fundamental researches about deep 
understanding of role of molecular structure and supramolecular organization of organic compounds 
in the formation of preferably oriented thin film over a substrate are much needed. Further, impact of 
external constraints like rigid wall (substrate) or thermal gradient on the occurrence of polymorph are 
also equally required. Crystallization of organic compounds on a solid surface can leads to stabilization 
of one particular polymorphic phase of the compound or formation of a new polymorphic phase [2], 
termed as substrate induced phase (SIP). In compare with conventional methods like spin coating or 
drop casting for the preparation of thin film, the use of thermal gradient method can enhance the 
supramolecular order in the thin film. Hence use of this technique in obtaining of large uniaxially 
oriented domain over a substrate is recent focus [3].  
 
In current work, a technique of crystallization of different organic compounds, for example, resorcinol, 
in a thermal gradient over a glass substrate has been performed. Role of molecular and crystal 
structure of the compound, thermal gradient magnitude, growth rate and polymorphism in formation 
of preferably oriented or aligned thin film have been investigated. A detail structural and orientation 
analysis of the thin film over the substrate has been performed by polarized optical microscopy, X-ray 
diffraction measurement and pole figure analysis. It was observed that in case of resorcinol, only beta 
form is appeared to crystallize over a glass or PDMS coated glass substrate in a thermal gradient. 
Moreover, well oriented crystals over the substrate were observed to be aligned relative to the 
temperature gradient. 
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ABSTRACT: Currently, the most important studies of halogen bonding that could find great use in the 
construction of supramolecular metal-organic architectures have generally been performed on single-
component systems. Multicomponent halogen bonded metal-organic systems, where an organic 
ligand functions as a halogen bond acceptor are still rare in literature.[1,2] Since our previous research 
has indicated the acetyl fragment as an acceptor species of interest,[3,4] in this work, we were 
interested in cocrystallizing robust metal complexes containing that fragment on its periphery. We first 
synthesized two coordination compounds of our selected ligand, n4aa (derived from 2-hydroxy-1-
naphthaldehyde and 4-aminoacetophenone), with copper(ii) and nickel(ii) ions, Cu(n4aa)2 and 
Ni(n4aa)2, respectively, after which they were cocrystallized with selected perflourinated halogen bond 
donors: iodopentafluorobenzene (ipfb), 1,4-diiodotetrafluorobenzene (1,4-tfib), 1,3-
diiodotetrafluorobenzene (1,3-tfib), and 1,4-dibromotetrafluorobenzene (1,4-tfbb). 
 
Cocrystal screening experiments were performed by liquid-assisted grinding mixtures of the metal 
complexes with the selected halogen bond donors, and the products were then characterized by 
powder X-ray diffraction. Powder patterns have revealed that cocrystals are formed in all these cases, 
and also that the corresponding Cu(n4aa)2 and Ni(n4aa)2 cocrystals are isostructural. Single crystals 
were obtained by traditional solution based crystallization methods. 
 
The supramolecular bonding topology of our obtained cocrystals was found out to be dependent on 
the topicity of the used halogen bond donor. Cocrystals with the monotopic halogen bond donor, 
ipfb
halogen bonds and the other which participates exclusively in C
cocrystals with linear ditopic halogen bond donors, 1,4-tfib and 1,4-tfbb, the dominant 
chains (1D). The 
chains are then stacked via C
into a 3D network via C 1,3-tfib, a longer and a 
d and lead to the formation of a layered architecture (2D). The 
layers are then stacked via long C  
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ABSTRACT: Pharmaceutical co-crystals represent an emerging class of crystalline solids formed by at 
least one API (active pharmaceutical ingredient) and an appropriate component, laying in the same 
crystal lattice and held together by weak interactions (hydrogen bond, halogen bond, - stacking).[1] 
Recently, multi-drug co-crystals (MDC) are turning out to be an alternative method to traditional fixed-
dose drug combinations.[2,3] Actually, these particular solid forms of APIs could overcome some 
disadvantages of combination drugs, such as low solubility and bioavailability and issue with stability 
of unstable components which can be enhanced through intermolecular interactions. Moreover, MDCs 
fulfill the criteria for patent eligibility: novelty, utility and non-obviousness. 
 
Structural characterization of co-crystals is extremely important because the outcome properties 
depend on the 3D arrangement of the molecules in the lattice. Single crystal X-ray diffraction (SCXRD) 
is usually considered as the best tool for structural studies, always more often supported and 
complemented by solid-state nuclear magnetic resonance (SSNMR), particularly when dealing with 
hydrogen atom positions.[4,5] 
 
We report on the synthesis and characterization of a theophylline-pyridoxine drug-drug co-crystal, 
whose two APIs are known to be concurrently administered for asthma treatment. The co-drug has 
been characterized by IR-ATR and Raman spectroscopy, thermal analysis (DSC and TGA), powder and 
single crystal X-ray diffraction, SSNMR measurements and DFT calculation.  
 
All these experiments have been fundamental to completely describe the molecular structure and the 
intermolecular interactions. SSNMR and DTF calculation have been crucial to unravel the complex 
hydrogen bond network and to define the ionic character of the drug-drug co-crystal, which can be 
more properly defined as drug-drug salt co-crystal. 
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ABSTRACT: Crystal Structure Prediction (CSP) studies aim to predict all the thermodynamically 
plausible crystal structures of a molecule from the chemical diagram, and so can act as a complement 
to the solid form screening work carried out in drug development [1]. However, most pharmaceuticals 
have several bulky molecular fragments linked by flexible torsion angles. Hence, determining the 
range of conformations that a flexible pharmaceutical could plausibly adopt in a crystal structure is a 
key to successful CSP studies. We develop a workflow for this purpose based on using conformational 
information retrieved from the Cambridge Structural Database (CSD) [2], which contains more than 
850,000 experimentally-determined crystal structures.  
 
The conformations produced by the CSD Conformer Generator are reduced by considering the 
underlying rotamer distributions, an analysis of changes in molecular shape, and a minimal number of 
molecular ab initio calculations. This workflow is tested for five pharmaceutical-like molecules, where 
an extensive CSP study had already been performed, namely molecules XXIII and XXVI from the 6th 
Blind Test, molecule XX from the 5th Blind Test, GSK269984B and mebendazole [3-6]. The CSD 
informatics-derived set of CrystalPredictor searches generates almost all the low-energy crystal 
structures previously found, including all experimental structures, whilst significantly reducing the 
computational cost. The issues involved in comparing solid-state and isolated-molecule conformations 
are discussed. 
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ABSTRACT: Solid-state synthesis (S3) is recognised as an attractive approach to synthesise new and 
existing molecules with minimal solvent waste and high yield. However, S3 not yet of general utility, 
being limited by poor understanding of which functional groups and reaction types are best suited for 
widespread implementation. 
 
In this report, we apply S3 to prepare eight Schiff bases,[1] seven of which are novel, in high yield 
(˃95%) using either mechanochemistry via solvent-drop grinding[2] followed by heating or a solution-
based method. The synthesised Schiff bases were designed to possess specific  functional groups and 
were selected for their potential utility as linker ligands to generate various types of 3D coordination 
networks with diamondoid (dia)[3] or primitive cubic (pcu) [4] topologies. All eight compounds were 
characterised using spectroscopy and single crystal X-ray diffraction, can be prepared in gram 
quantities and exhibit high thermal stabilities. They therefore are promising for application as linker 
ligands in Metal Organic Materials, MOMs. 
 
Our synthetic approach will not only afford new materials and enables molecular diversity, but it also 
provides a rapid and environmentally friendly methodology for the construction of molecular and 
supramolecular materials. 
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ABSTRACT: Organic compounds with both hydrogen bond (H-bond) donor and acceptor functional 
groups connected to a benzene ring have been widely used to investigate how H-bond interactions 
can be used to engineer crystals with specific packing motifs and physicochemical properties.[1] This 
type of compounds is also often implicated in discussions of crystallization and polymorphism 
involving molecular organic solids, which are intimately related to crystal engineering strategies. A 
fundamental aspect within this scope is the understanding of how systematic changes in molecular 
structure influence packing patterns, lattice energies, and phase transitions in crystals. Compounds of 
4-HOC6H4COR type (R = H, alkyl) are interesting systems to investigate these questions, because they 
are prone to polymorphism[2-5] and have also shown some unique features in terms of crystallization 
behavior.[6,7] In this work a systematic study covering structural aspects, lattice energies, and phase 
transitions for the 4-HOC6H4COR compounds in Figure 1 will be presented. Also addressed will be the 
co-crystalization of 4-HOC6H4COCH3 with different co-
molecules can interfere with the 4-HOC6H4COR packing. 
 
 
Figure 1. Molecular structures of the compounds studied in this work. 
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ABSTRACT: In the pharmaceutical field, solid state chemistry and the discovery of new solid forms[1] of 
active pharmaceutical ingredients (APIs) are very significant. Co-crystallization[2] or salt formation[3] can 
provide an efficient strategy to obtain new APIs. 
 
This project was focused on the improvement of the solubility properties of venlafaxine (RS)-1-[2-
dimethylamino-1-(4-methoxyphenyl)-ethyl]cyclohexanol, an antidepressant in a group of drug called 
Selective Serotonin and Norepinephrine Reuptake Inhibitors (SSNRIs), used for the treatment of Major 
Depressive Disorder (MDD) and generalized anxiety disorder. 
 
The goal of the project was the preparation of new venlafaxine salts by salt formation between 
venlafaxine free base and co-formers accepted in Pharmacopeia and the subsequent tablet 
formulation with excipients. Three of the new salts were chosen for the tablet formulations with 
excipient and the in vitro dissolution tests in accordance to the United States Pharmacopeia (USP). 
Dissolution tests were compared with those of the commercial form of venlafaxine: venlafaxine 
hydrochloride. 
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ABSTRACT:  
 After expiration in 2012 of the patent protection for the blockbuster drug Clopidogrel (Plavix®, Sanofi-
Aventis), it has been challenging for drug manufacturers to launch generic forms with improved 
physicochemical properties and biopharmaceutical performances [1]. Therefore our aim was a 
cocrystallization screening by crystal engineering approach for new molecular salts of the more active 
and better tolerated form of clopidogrel, the dextrorotary isomer S(+)clopidogrel, followed by 
structural determination. Few structures of this drug exist so far in the Cambridge Structural Database 
(CSD v.5.35): the two polymorphs of S(+)clopidogrel hydrogen sulfate used in pharmaceutical 
formulations, orthorhombic form II (refcode FUQMOU) and monoclinic form I (FUQMOU01) [2,3], as well 
as the S(+)clopidogrel camphosulfonate (JASHUG) [4] and S(+)clopidogrel isopropylsulfate (YEXHOZ) 
[5].  
 
The crystal structures of two new pseudo-polymorphic forms of S(+)clopidogrel-picrate salt obtained 
by co-crystallization are reported. Compound 1 (CDCC 1448941), prepared by treating clopidogrel 
hydrogen sulfate with picric acid, crystallizes in the monoclinic space group P21 with a ionic couple 
- and a molecule of solvent ethanol in the A.U.. Crystals of Compound 2 (CDCC 
1448942), grown dissolving clopidogrel free base and picric acid in a methanol/n-propanol mixture, 
crystallize in the monoclinic space group C2 with two ionic couples in the A.U.. The configurations and 
conformations of the ionic couples, held together by quite strong ionized +N─H···
(H-bonds), are almost identical in both crystals.  
 
The two compounds are compared with known structures of clopidogrel salts, including those used in 
pharmaceutical formulations, and the H-bonds discussed in reference to the general behavior of the 
N-bases-picrate H-bond and to the coformers acid-base properties. d(N···O) contact distances are in 
the range 2.752-2.815 Å with calculated H-bond energy from 2.68 to 3.45 kcal mol-1 and pKa of -
4.26. These medium-strong H-bonds fit well the reported correlations among d(D···A), EHB, and pKa [6] 
aimed to verify the validity of the pKa equalization principle [7-9]. 
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ABSTRACT: Over the last few years, studies on quantification and determination of various polymorph 
forms in complex matrices have become a key point in research by pharmaceutical industries. Studies 
on their quantification are also requested by the FDA, because the various polymorphs are 
characterized by a different bioavailability in the organism. In our studies we would like to improve 
simple method for the quantification of a crystalline phase in presence of a complex matrix which 
comprises several phases and amorphous. The method consists in an X-ray diffractometric analysis 
combined with the partial least square. The analyzed drugs are the Budesonide (BDS), a glucocorticoid 
used for the treatment of asthmatic pathologies and the Tachifludec, whose API is paracetamol, 
commonly used for inflammatory diseases. This work is done by preparing  through the method of 
standard addition  specimens that will be submitted to XRPD. The obtained diffractograms are then 
submitted to multivariate analysis through partial least square 1, by using the Unscrambler 10.4 
software. The main advantage of chemometrics is its easy applicability. Moreover, thanks to the data 
obtained by the multivariate regression, it can be confirmed that the chosen method is extremely valid 
to solve these kinds of problem. 
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ABSTRACT: Nowadays, the exploration and synthesis of novel crystal forms is a well-established 
strategy for tuning physicochemical properties of a certain molecule while preserving its inherent 
activity.[1] A particular type of crystal form is represented by pharmaceutical cocrystals where at least 
one component is an Active Pharmaceutical Ingredient (API).[2] If both co-formers are APIs, a co-drug, 
or drug-drug cocrystal, is formed. This is a convenient approach, when the two APIs are used in 
combination to treat a specific disease, to reduce the pill burden and also minimize any possible 
mistake by patients.[3] Moreover, sometimes drug-drug cocrystallization may represent also a strategy 
to tune the performances of APIs.[4] 
 
This poster reports on the preparation and solid-state characterization of an indomethacin-caffeine co-
drug in a 1:1 stoichiometry. These two active ingredients are frequently co-administered as part of a 
therapy against strong migraines, in a commercially available fixed dose combination formulation. The 
X-ray crystal structure of the co-drug is characterized by a hydrogen bond interaction between the 
carboxylic moiety of indomethacin and the purinic nitrogen atom of caffeine. Dissolution kinetic tests 
revealed superior bioavailability of indomethacin in the co-drug compared to indomethacin alone. On 
the other hand, the thermal stability of indomethacin was lower in the cocrystal rather than in the pure 
drug. 
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ABSTRACT: An ionic co-crystal (ICC) is a multicomponent solid formed by at least an organic molecule 
and an inorganic salt in a defined stoichiometric ratio. ICCs have the potential to alter physicochemical 
properties (such as solubility and thermal stability) of a pure organic material of interest. The purpose 
of the current work was to investigate the possibility of chiral resolution by ICC formation. ICCs of DL-
proline and DL-histidine[1] with lithium halides were synthesized and investigated whether a racemate 
ICC or a conglomerate of L- and D-ICC wаs formed. Green chemistry methods were used for synthesis. 
 
The performed investigations highlighted the potential for chiral resolution in the solid-state induced 
by Li+; depending on the chosen halide we were able to observe the formation of a conglomerate 
and/or a racemate ICC. The racemate ICC can be described as a special type of co-crystals made of 
enantiopure L- and D-amino acids chains of the same type as those obtained with enantiopure L-amino 
acid. The obtained results encourage further research to establish the homochiral preference of 
lithium cation and to identify the factors that promote conglomerate formation versus the formation of 
a racemate ICC through co-crystallization. 
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ABSTRACT: Over the last years, Pharmaceutical Industry has faced some drawbacks regarding the 
poor aqueous solubility and low bioavailability of several Active Pharmaceutical Ingredients (APIs) 
during drug development process. To overcome these issues, without changing the pharmacological 
behavior of the APIs, methods such as co-crystallization and salt formation are being employed.[1] 
 
Amantadine is an anti-Parkinsonian API used to reduce some of the symptoms, such as askinesia and 
rigidity, and to improve motor fluctuations. This API has a very low aqueous solubility and also 
bioavailability limitations, when administrated as hydrochloric and sulfate salt forms.[2] In order to 
improve its physicochemical properties, we synthesized several new salts using different organic acid 
derivatives. The structural characterization of the compounds was performed using single crystal X-ray 
diffraction, DFT calculations, solid-state NMR and X-ray powder diffraction. DSC-TGA analysis and 
solubility tests are underway.[3] Here we report and discuss some of the interesting results, with major 
focus on structure determination using X-ray powder data. 
 
 
 
Acknowledgements: The authors acknowledge funding of the projects UID/QUI/00100/2013 and 
SFRH/BD/93140/2013 by Fundação para a Ciência e a Tecnologia. 
 
 
 
 
 
 
 
References: 
[1] D. Braga, L. Maini, F. Grepioni, Chem. Soc. Rev. 2013, 42, 7638 7648.  
[2] J. Jankovic, L. G. Aguilar, Neuropsychiatr. Dis. Treat. 2008, 4, 743 757.  
[3] I. C. B. Martins, A. Bodach, E. Alig, M. Sardo, L. Mafra, L. Fink, M. U. Schmidt, M. T. Duarte - Article under 
preparation. 
9th -6 June 2017                                                                                                 31 
 
POSTER No. 29 
 
Hydrogel-membrane composite materials: promising materials for protein crystallization 
Benny Danilo, Belviso,a Rocco, Caliandro,a Gianluca Di Profio,b Mariella Polino,c Fiore Pasquale 
Nicoletta,d Enrica Fontananova,b Giovanni De Filpo,d Efrem Curcio,e Enrico Driolie 
a Istituto di Cristallografia, CNR, Bari, Italy, danilo.belviso@ic.cnr.it 
b Istituto per la Tecnologia delle Membrane, CNR, Arcavacata di Rende (CS), Italy 
c Facoltà di Farmacia e Scienze della Salute e della Nutrizione, Università della Calabria, Arcavacata di 
Rende (CS), Italy 
d Dipartimento di Chimica e Tecnologie Chimiche, Università della Calabria. Arcavacata di Rende (CS), 
Italy 
e Dipartimento di Ingegneria per l'Ambiente e il Territorio e Ingegneria Chimica, Università della 
Calabria, Arcavacata di Rende (CS), Italy 
 
ABSTRACT: X-ray diffraction techniques allow obtaining of molecular structures at a resolution level at 
the moment not still surpassed by other techniques. However, obtaining crystal samples having quality 
suitable for diffraction experiment represents the bottleneck in the structure determination process, 
particularly in the case of protein molecules due to their weak intermolecular interactions, flexibility, 
and to the contribution of solvent on their aggregation. A turning point in this field could be 
represented by the use of new materials which could be able to extend the range of the experimental 
conditions able to trigger nucleation.[1] An example is represented by gel-mediated protein 
crystallization that is able to produce high quality crystals[2] that are particularly suitable for soaking 
experiments with drugs of foreign molecules due to their resistance to the osmotic stress.[3] However, 
the low consistency and fragility of the gel materials restricts the use of such technique for which a 
support for gel is required. Hydrophobic membranes have been already tested as support for protein 
crystallization, showing ability to modulate the solvent exchange and to trigger heterogeneous 
nucleation.[4] In addition, their flexibility makes them suitable as support for gels during crystallization 
experiments.  
 
Here, we purpose an innovative approach for protein crystallization that exploit a material made of 
hydrogel and membrane able to combine the advantages of crystallization in gel with those of 
membrane-assisted crystallization.[5] Crystallization by hydrogel-membrane material has been tested 
on two proteins, leading to crystals that grow at lower protein concentration and having improved 
diffraction properties than those produced by means of conventional technique. As prospective, the 
material can be optimized to promote membrane proteins crystallization, for biomineralization, and 
non-classical mesocrystal structures. 
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ABSTRACT: In drug discovery of new chiral active pharmaceutical ingredients, the determination of 
the absolute structure configuration is extremely important. Having the wrong enantiomer could be 
crucial or even devastating [1]. Single crystal X-ray diffraction is the most precise analytical method to 
confirm the absolute configuration. However, in order to do so, a single crystal is needed. In many 
cases growing single crystals could be very difficult or even "impossible". Crystallise! AG (Switzerland), 
a company dedicated to single crystal growth and X-ray characterization, has achieved unprecedented 
results in this area [2,3]. A single crystal of a light atom (C, H, N, O) penta-peptide API, was grown in 
only four weeks after receiving the sample. Other competitors had tried for a period of four years 
without success. Using synchrotron radiation Crystallise! succeeded not only in getting the crystal 
structure but also in confirming the absolute configuration [4]. 
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